Treatment Abandonment: Cause of Preventable Death in Children with Cancer

Authors

  • Amaranto Suárez Instituto Nacional de Cancerología
  • Carolina Guzmán Instituto Nacional de Cancerología
  • Bibiana Villa Instituto Nacional de Cancerología
  • Óscar Gamboa Instituto Nacional de Cancerología

Keywords:

Neoplasms, child, abandoned, therapy, survival, developed countries, developing countries

Abstract

Objective: A cohort of children with cancer was analyzed to determine the risks of relapse or death in patients who abandoned treatment, as well as to explore causes for abandonment.
Methods: A retrospective cohort study was carried out with 303 patients, under age 23, from January 1998 to December 2000. Data were obtained from medical records and a telephone survey. Descriptive statistics were used to determine frequencies of category variables; contingency tables and calculation of the test, or the Exact Fisher Test, determined the association of variables with abandonment, in cases which did not fulfill Chi2 suppositions. Hazard ratio (HR) of treatment failure was calculated with the Cox regression model and survival analysis with the Kaplan-Meier method.
Results: A total of 17.87% patients abandoned treatment. Relapse and mortality were associated with treatment failure (P=0.001). Bivariate analysis revealed that the risks of relapse and abandonment were the only variables associated with development of event. Adjusted HR for abandonment and relapse risk was 3.90 (CI 95%; 2.27-6.77) and 2.24 (CI 95%; 1.29-3.88), respectively. The remaining variable showed no significant results.
Conclusions: Treatment abandonment at 17.87% is high compared to developed countries, and reveals an accentuated tendency to be associated with relapse and death.

Author Biographies

Amaranto Suárez, Instituto Nacional de Cancerología

Clínica de Oncología Pediátrica, Instituto Nacional de Cancerología, Bogotá D.C., Colombia

Carolina Guzmán, Instituto Nacional de Cancerología

Clínica de Oncología Pediátrica, Instituto Nacional de Cancerología, Bogotá D.C., Colombia

Bibiana Villa, Instituto Nacional de Cancerología

Clínica de Oncología Pediátrica, Instituto Nacional de Cancerología, Bogotá D.C., Colombia

Óscar Gamboa, Instituto Nacional de Cancerología

Subdirección de Investigaciones, Vigilancia Epidemiológica, Promoción y Prevención, Instituto Nacional de Cancerología, Bogotá D.C., Colombia

References

Sackett D, Haynes R, Guyatt G, et al. Ayudar a los pacientes a cumplir los tratamientos. En: Epidemiología clínica. Ciencia básica para la medicina clínica. 2ª ed. Bogotá: Médica Panamericana; 1994. p. 249-78.

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.

https://doi.org/10.1056/NEJMra050100

Wilimas JA, Ribeiro R. Pediatric haematology oncology outreach for developeing contries. Hematol Oncol Clin North Am. 2001;15:75-87.

https://doi.org/10.1016/S0889-8588(05)70246-X

Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lynphoblastic leukaemia in resource poor countries. The Lancet 2003; 362:706-08.

https://doi.org/10.1016/S0140-6736(03)14228-6

Masera G, Baez F, Biondi A, et al. Bridging the chilhood cancer mortality gap between economically developed and low-income countries: Lesson from the MISPHO experience. En: Tanneberger S, Cavalli F, Pannuti F, editores. Cancer in developing countries. The great challenge for oncology in the 21st century. Kornwestheim: Zuckschwerdt Verlag; 2004. p. 42-60.

Lilleyman, J. Simple deliverable therapy needed for childhood leukaemia. Lancet. 2003;362:676-7.

https://doi.org/10.1016/S0140-6736(03)14241-9

Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71:3441-9.

https://doi.org/10.1002/1097-0142(19930515)71:10+<3441::AID-CNCR2820711751>3.0.CO;2-P

Huchcroft SA, Snodgrass T. Cancer patients who refuse treatment. Cancer Causes and Control. 1993;4:179-85.

Lewis C, Linet MS, Abeloff MD. Compliance with cancer therapy by patients and physicians. AJM. 1983;74:673-8.

https://doi.org/10.1016/0002-9343(83)91026-4

Ribeiro RC, Pui Ch-H. Saving the children. Improving childhood cancer treatment in developing countries. N Engl J Med. 2005;352:2158-60.

https://doi.org/10.1056/NEJMp048313

Gurney JG, Bondy ML. Epidemiology of childhood cancer. En: Pizzo PA, Poplack DC, editores. Principles and practices of pediatric oncology. 5ª ed. Philadelphia: Lippinccott Williams and Wilkins; 2006. p. 1-13.

Magrath I, Shad A, Epelman S, et al. Pediatric oncology in countries with limited resources. En: Pizzo PA, Poplack DG, editores. Principles and practices of pediatric oncology. 3 ed. Philadelphia: Lippinccott-Ravet; 1997. p. 1395-420.

Spinetta J, Masera G, Eden T, et al. Refusal, non-complice, and abandonment of treatment in children and adolescents with cancer: a report of the SIOP working committee on phychosocial issues in pediatric oncology. Med Pediatr Oncol. 2002;38:114-7.

https://doi.org/10.1002/mpo.1283

Organización Mundial de la Salud (OMS). Adherencia a los tratamientos a largo plazo: Pruebas para la acción. Ginebra: OMS; 2004.

Usmani G. Pediatric oncology in the third world. Curr Opin Pediatr. 2001;13:1-9.

https://doi.org/10.1097/00008480-200102000-00001

Pui C-H, Schrappe M, Tognoni G, et al. All children have a right to full access to treatment for cancer. Lancet. 2004;364:1121-2.

https://doi.org/10.1016/S0140-6736(04)17089-X

Valsecchi M.G, Tognoni G, Bonilla M, et al. Clinical epidemiology childhood cancer in Central America and Caribbean countries. Ann Oncol. 2004;15:680-5.

https://doi.org/10.1093/annonc/mdh148

Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukaemia in a resource poor area. JAMA. 2004;291:2471-5.

https://doi.org/10.1001/jama.291.20.2471

Bonilla M, Moreno N, Marina N, et al. Acute lynphoblastic leukaemia in a developing country: Preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol. 2000;22:495-501.

https://doi.org/10.1097/00043426-200011000-00004

Karakas Z, Agaoglu L, Biner B, et al. Result of rhabdomyosarcoma treatment in a developing country. Acta Med Okayama. 2000;54:173-7.

Meremikwu MM, Ehiri JE, Nkanga DG, et al. Socioeconomic constraints to effective management of Burkitt's lymphoma in South-Estern Nigeria. Trop Med Int Health 2005;10:92-98.

https://doi.org/10.1111/j.1365-3156.2004.01348.x

How to Cite

[1]
Suárez, A. et al. 2011. Treatment Abandonment: Cause of Preventable Death in Children with Cancer. Revista Colombiana de Cancerología. 15, 1 (Mar. 2011), 22–29.

Downloads

Download data is not yet available.

Issue

Section

Research/original articles